PHARMACOKINETICS, PHARMACODYNAMICS, AND TOLERABILITY OF VERINURAD (RDEA3170), A SELECTIVE URIC ACID REABSORPTION INHIBITOR, IN HEALTHY JAPANESE MALE SUBJECTS

被引：0
|
作者：
Gillen, M. [1 ]
Miner, J. N. [2 ]
Valdez, S. [2 ]
机构：
[1] AstraZeneca, Gaithersburg, MD USA
[2] Ardea Biosci Inc, San Diego, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.5200
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0887
引用
收藏
页码：1366 / 1366
页数：1
相关论文
共 50 条
  • [1] PHARMACOKINETICS, PHARMACODYNAMICS, AND TOLERABILITY OF VERINURAD (RDEA3170), A SELECTIVE URIC ACID REABSORPTION INHIBITOR, IN HEALTHY ADULT MALE SUBJECTS
    Gillen, M.
    Shen, Z.
    Miner, J. N.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1366 - 1366
  • [2] Pharmacokinetics, Pharmacodynamics, and Tolerability of Verinurad, a Selective Uric Acid Reabsorption Inhibitor, in Healthy Japanese Male Subjects
    Gillen, Michael
    Miner, Jeffrey N.
    Valdez, Shakti
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [3] Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy adult male subjects
    Shen, Zancong
    Gillen, Michael
    Miner, Jeffrey N.
    Bucci, Gail
    Wilson, David M.
    Hall, Jesse W.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2077 - 2086
  • [4] Pharmacokinetics, Pharmacodynamics, and Tolerability of Verinurad, a Selective Uric Acid Reabsorption Inhibitor, in Healthy Adult Male Subjects
    Gillen, Michael
    Shen, Zangong
    Miner, Jeffrey N.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [5] Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Multiple Dose Administration of Verinurad (RDEA3170) and Febuxostat in Healthy Adult Male Subjects
    VanderLugt, James
    Gillen, Michael
    Yang, Xiaojuan
    Hall, Jesse
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [6] PHARMACOKINETICS, PHARMACODYNAMICS, AND TOLERABILITY OF CONCOMITANT MULTIPLE DOSE ADMINISTRATION OF VERINURAD (RDEA3170) AND FEBUXOSTAT IN HEALTHY ADULT MALE SUBJECTS
    VanderLugt, J. T.
    Gillen, M.
    Yang, X.
    Hall, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 370 - 370
  • [7] Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy Japanese and non-Asian male subjects
    Hall, Jesse
    Gillen, Michael
    Liu, Sha
    Miner, Jeffrey N.
    Valdez, Shakti
    Shen, Zancong
    Lee, Caroline
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1799 - 1807
  • [8] Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Multiple Dose Administration of Verinurad (RDEA3170) and Allopurinol in Adult Male Subjects with Gout
    Hall, Jesse
    Gillen, Michael
    Yang, Xiaojuan
    Liu, Sha
    Walker, Susan
    Clauson, Vicki
    Kankam, Martin
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [9] PHARMACOKINETICS, PHARMACODYNAMICS, AND TOLERABILITY OF CONCOMITANT MULTIPLE DOSE ADMINISTRATION OF VERINURAD (RDEA3170) AND ALLOPURINOL IN ADULT MALE SUBJECTS WITH GOUT
    Hall, J.
    Gillen, M.
    Yang, X.
    Liu, S.
    Walker, S.
    Clauson, V.
    Kankam, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 370 - 371
  • [10] Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Multiple Dose Administration of Verinurad (RDEA3170) and Allopurinol in Adult Male Subjects With Gout
    Kankam, Martin
    Hall, Jesse
    Gillen, Michael
    Yang, Xiaojuan
    Shen, Zancong
    Lee, Caroline
    Liu, Sha
    Miner, Jeffrey N.
    Walker, Susan
    Clauson, Vicki
    Wilson, David
    Mai Nguyen
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (09): : 1214 - 1222
12345